Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 Progressive Pulmonary Fibrosis 5 2025-04-07
The MIRAGE study. Use of radioactively labelled deferoxamine for a novel purpose: imaging pulmonary aspergillosis with PET/CT scans. Recruiting

2023-509744-10-00 Pulmonary aspergillosis 4 2025-04-01
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis Recruiting

2024-514845-12-00 Non-Cystic Fibrosis Bronchiectasis 4 2025-03-28
PHASE III, DOUBLE-BLIND, RANDOMIZED, CONTROLLED, NON-INFERIORITY, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY OF SALBUTAMOL MONOTHERA… Recruiting

2024-514065-19-00 Acute asthma. Patients with moderate asthma attacks wil 5 2025-03-27
A study to investigate changes in symptoms in adult participants with chronic rhinosinusitis with nasal polyposis initiating treatment with … Recruiting

2024-513862-20-00 Chronic Rhinosinusitis with Nasal Polyposis 5 2025-03-26
First-line immunotherapy-based standard of care and local ablative treatments for oligometastatic non-small cell lung cancer patients: a ran… Recruiting

2023-503326-39-00 Synchronous oligometastatic non-small cell lung cancer 5 2025-03-06
Whole body HER3 quantification with radiolabelled Patritumab deruxtecan (HER3-DXd) PET/CT Recruiting

2023-508233-14-00 EGFR mutation positive advanced stage NSCLC 4 2025-03-03
Local Antibiotic Delivery for Community Acquired Pneumonia - Pilot study (LANDCAP1) Recruiting

2024-511413-37-00 Community-acquired pneumonia 4 2025-03-03
Molecular signatures associated with response to ICS treatment in patients with COPD stratified by eosinophil levels Recruiting

2023-505245-13-00 Chronic obstructive pulmonary disease (COPD) 6 2025-02-12
A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Recruiting

2022-502877-41-01 Pulmonary sarcoidosis with or without extrapulmonary ma 9 2025-02-10
BONG: Reducing severe Breathlessness with Dronabinol in the severe and very severe chronic obstructive pulmonary disease patient group Recruiting

2024-513593-22-00 Chronic obstructive pulmonary disease 10 2025-01-31
Effect of oxygen administration in the non-dependent lung on postoperative complications after lung surgery Recruiting

2024-517599-39-00 Lung Resection Surgery 6 2025-01-27
The effect of additional pre-extubational loading dose of caffeine-citrate Recruiting

2024-519041-29-02 Extubation failure and bronchopulmonary dysplasia 6 2025-01-15
EvER-ILD 3 : Evaluation of Efficacy and safety of Rituximab and mycophenolate mofetil combination in patients with Interstitial Lung Disease… Recruiting

2023-510507-21-00 Intersitial lung disease related to systemic sclerosis 10 2025-01-08
A WORLD-WIDE CLINICAL STUDY TO FIND OUT IF INTRAVENOUS RECOMBINANT HUMAN PLASMA GELSOLIN IS SAFE AND IS BENEFICIAL FOR TREATING ACUTE RESPIR… Recruiting

2023-510109-16-00 Acute Respiratory Distress Syndrome (ARDS) Due to Pneum 4 2025-01-06
Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions (DEXA-REFINE) Recruiting

2024-519759-27-00 Acute Hypoxemic Respiratory Failure 6 2024-12-20
Study of prevention of respiratory infections through the drug OM85 in elderly patients Recruiting

2024-513592-41-00 Elderly patients with a positive history of at least tw 6 2024-12-19
ChemoRadiotherapy with Or Without surgery followed by consolidation Durvalumab (CROWD): a phase IV feasibility trial Recruiting

2024-511711-21-00 Stage III non-small cell lung cancer 6 2024-12-16
STOP-COPD Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease Recruiting

2022-502003-30-00 Acute Exacerbation of Chronic Obstructive Pulmonary Dis 6 2024-12-11
Pulmonary pharmacokinetics of piperacillin/tazobactam and levofloxacin in patients with chronic obstructive pulmonary disease or cystic fibr… Recruiting

2024-518337-29-00 chronic obstructive pulmonary disease 6 2024-12-11
Study of the compound RCS-21 on the safety of healthy volunteers, its tolerability and on the way the body absorbs, distributes, and gets ri… Recruiting

2024-512351-21-00 Safety, tolerability and pharmacokinetics of single-as 1 2024-12-10
Protecting late-moderate preterm infants from respiratory tract infections and wheeze in their first year of life by using bacterial lysates Recruiting

2024-518498-32-01 Lower respiratory tract infections and wheezing in mode 5 2024-12-05
An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa… Recruiting

2024-517820-21-00 cystic fibrosis associated to persistent Staphylococcus 4 2024-11-29
Respiratory rehabilitation in patients with ILD Recruiting

2024-519541-30-00 ILD 5 2024-11-27